Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigitte M Pützer

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
Oncotarget|January 9, 2014
DNp73: oncotarget in invasion and metastasisBrigitte M Pützer
Discovery Medicine|January 20, 2007
Targeting E2F1 death signaling: opposing role in cancer control and neurodegenerationBrigitte M Pützer
Nature Clinical Practice. Oncology|October 5, 2006
Mechanisms of Disease: cancer targeting and the impact of oncogenic RET for medullary thyroid carcinoma therapyMatthias Drosten, Brigitte M Pützer
Trends in Molecular Medicine|March 15, 2006
E2F1-induced apoptosis: turning killers into therapeuticsJens Stanelle, Brigitte M Pützer
Trends in Molecular Medicine|July 10, 2004
The RET proto-oncogene: a potential target for molecular cancer therapyBrigitte M Pützer, Matthias Drosten
Cell Cycle (Georgetown, Tex.)|June 29, 2010
Checks and balances: E2F-microRNA crosstalk in cancer controlStephan Emmrich, Brigitte M Pützer
Trends in Molecular Medicine|December 11, 2012
E2F1 apoptosis counterattacked: evil strikes backBrigitte M Pützer, David Engelmann
Journal of Molecular Medicine (Berlin, Germany)|June 18, 2003
Gene therapeutic approaches for medullary thyroid carcinoma treatmentMatthias Drosten, Brigitte M Pützer
Cancer Research|February 3, 2012
The dark side of E2F1: in transit beyond apoptosisDavid Engelmann, Brigitte M Pützer
Viruses|March 28, 2024
Novel Viral Vectors for Gene TherapyOttmar Herchenröder, Brigitte M Pützer
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
Oncotarget|January 9, 2014
DNp73: oncotarget in invasion and metastasisBrigitte M Pützer
Discovery Medicine|January 20, 2007
Targeting E2F1 death signaling: opposing role in cancer control and neurodegenerationBrigitte M Pützer
Nature Clinical Practice. Oncology|October 5, 2006
Mechanisms of Disease: cancer targeting and the impact of oncogenic RET for medullary thyroid carcinoma therapyMatthias Drosten, Brigitte M Pützer
Trends in Molecular Medicine|March 15, 2006
E2F1-induced apoptosis: turning killers into therapeuticsJens Stanelle, Brigitte M Pützer
Trends in Molecular Medicine|July 10, 2004
The RET proto-oncogene: a potential target for molecular cancer therapyBrigitte M Pützer, Matthias Drosten
Cell Cycle (Georgetown, Tex.)|June 29, 2010
Checks and balances: E2F-microRNA crosstalk in cancer controlStephan Emmrich, Brigitte M Pützer
Trends in Molecular Medicine|December 11, 2012
E2F1 apoptosis counterattacked: evil strikes backBrigitte M Pützer, David Engelmann
Journal of Molecular Medicine (Berlin, Germany)|June 18, 2003
Gene therapeutic approaches for medullary thyroid carcinoma treatmentMatthias Drosten, Brigitte M Pützer
Cancer Research|February 3, 2012
The dark side of E2F1: in transit beyond apoptosisDavid Engelmann, Brigitte M Pützer
Viruses|March 28, 2024
Novel Viral Vectors for Gene TherapyOttmar Herchenröder, Brigitte M Pützer
Pageof 10